What Must IT Professionals Know About The White House Paper On Secure And Measurable Software?
By Fabien Chouteau, Global Technical Marketing Lead, AdaCore In February 2024, The White House published…
Risk Management
Glencore Selects MetricStream Connected GRC to Accelerate Operational Governance, Risk and Compliance across its Industrial Business
San Jose, California, March 27, 2024: MetricStream, the global market leader in Governance, Risk and Compliance…
Cybersecurity in the Modern Era: Navigating Challenges and Solutions for Business Growth
Understanding the Current Cybersecurity Landscape By IT Business Net Staff In today’s rapidly evolving digital…
The Top 3 API Security Weak Spots
By Ali Cameron The API landscape is constantly expanding. More and more, companies are leveraging…
The Critical and Emerging Role of Bank Chief Risk Officers
By Roshni Patel, Global Head of Risk Solutions, Quantexa If you want to understand why…
EPKINLYTM (epcoritamab) Approved by Japan Ministry of Health, Labour and Welfare as the First Bispecific Antibody to Treat Adults Patients with Certain Types of Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)
Media Release Subcutaneous EPKINLYTM (epcoritamab) is the first and only bispecific antibody approved in Japan…
Repligen Appoints Jason K. Garland as Chief Financial Officer
WALTHAM, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company…
Repligen Appoints Jason K. Garland as Chief Financial Officer
WALTHAM, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company…
The Dangers of Public Wi-Fi
Reports suggest that 400 million Americans go on long distance business trips annually, and with…
Genmab and Seagen Announce That TIVDAK® (tisotumab vedotin-tftv) Met its Primary Endpoint of Improved Overall Survival in Patients with Recurrent or Metastatic Cervical Cancer Compared to Chemotherapy
Company Announcement Phase 3 innovaTV 301 confirmatory trial met its primary endpoint of improved overall…
Press Release: Sanofi announces changes to its Executive Committee
Sanofi announces changes to its Executive Committee Paris, August 31st, 2023. Sanofi announces the following…
Press Release: Sanofi announces changes to its Executive Committee
Sanofi announces changes to its Executive Committee Paris, August 31st, 2023. Sanofi announces the following…
Genmab to Present at Morgan Stanley 21st Annual Global Healthcare Conference
Media Release COPENHAGEN, Denmark; August 28, 2023 Genmab A/S (Nasdaq: GMAB) announced today that its…
Shadow IT Risks: How to Safeguard Your Organization & Navigate the Storm
By Ben Pippenger, CSO at Zylo Managing software can pose a real challenge for organizations….
BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update
Significant pipeline advancement highlighted by the initiation of BNT316/ONC-392 Phase 3 pivotal trial and multiple…
Genmab Announces Financial Results for the First Half of 2023
August 3, 2023 Copenhagen, Denmark; Interim Report for the First Six Months Ended June 30,…
Genmab Announces Financial Results for the First Half of 2023
August 3, 2023 Copenhagen, Denmark; Interim Report for the First Six Months Ended June 30,…
Genmab Updates 2023 Financial Guidance
Company Announcement COPENHAGEN, Denmark; July 28, 2023 – Genmab A/S (Nasdaq: GMAB) announced today its…
Genmab Announces AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
Company Announcement The positive CHMP opinion is supported by results from the EPCORE™ NHL-1 phase…
What to Look for in a Modern Insider Risk Solution
Insider threat can be described as the potential of an employee to utilize their authorised…